Last updated on: 17/09/2018
1. Contact details
This data source is maintained by the following centre registered in the ENCePP inventory of research centres: NIPH
Name of data sourceNorwegian Prescription Database
Name under which the data source should be displayed in the inventory (e.g short name if one exists)NorPD
Name of organisation
1) Department/research groupDivision of Health Data and Digitalisation
2) Organisation/affiliationNorwegian Institute of Public Health
Administrative Contact
Title Ms
Last name Husabø
First name Kari Jansdotter
Address line 1P.O.Box 222 Skøyen
Address line 2
Address line 3
CityOSLO
PostcodeNO-0213
CountryNorway
Scientific Contact
Title Dr
Last name Ebbing
First name Marta
Address line 1P.O.Box 222 Skøyen
Address line 2
Address line 3
CityOSLO
PostcodeNO-0213
CountryNorway
2. Description/category
Pharmacy dispensing database
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
Community / general practice data
All drugs prescribed (both reimbursed & nonreimbursed) by all kinds of physicians, dentists dispensed from all Norwegian pharmacies
3.2 ATC code (5th level)
Yes
3.3 Other product dictionaries
No
3.4 Recording of indication for use
Yes
Is a coding dictionary being used? ICD-10 or ICPC-2
4. Coverage of events
Event
Dictionary
Dictionary details
Death
Yes
month and year of death
5. Year of establishment
2004
6. Geographical origin of data
EEA/EFTA countries
Norway
7. Demographical extent of data collection
Nation-wide
8. Age groups
17 years and under [Paediatrics]
preterm newborn infants
term newborn infants (0 to 27 days)
infants and toddlers (28 days to 23 months)
children (2 to 11 years)
adolescents (12 to 17 years)
18 to 45 years
46 to 64 years
65 years and over
65 to 75 years
76 years and over
9. Size of the source/catchment population
5,295,619
10 a. Total (cumulative) number of persons with actual data
5,757,884
10 b. Number of persons with active data collection in past calendar year
3,688,097
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
No
b) Questionnaire data from the patient?
No
c) Genetic information or samples?
No
12. Possibility of links to other sources of data
Yes :
Other Norwegian Health registers like Medical Birth Registry, Cause of Death registry, Cancer Registry, Patient registry (hospital discharges and specialists outpatients (both somatic & psychiatry), health surveys, socioeconomic data etc
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
Yes
15. Charge/fee for data access
Yes
Special arrangements for academic purposes:
No
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
But A, De Bruin ML, Bazelier MT, Hjellvik V, Andersen M, Auvinen A, Starup-Linde J, Schmidt MK, Furu K, de Vries F, Karlstad Ø, Ekstrøm, N, Haukka J. Cancer Risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study. Diabetologia. 2017; 60, 1691-703.https://link.springer.com/content/pdf/10.1007%2Fs00125-017-4312-5.pdf
Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, Valdimarsdottir U, Zoega H, Artama M, Gissler M, Malm H, Nørgaard M. Serotonin-Reuptake Inhibitors and Venlafaxine in early pregnancy and risk of birth defects – a population based cohort study and sibling design. BMJ 2015. Apr 17;350:h1798http://www.bmj.com/content/bmj/350/bmj.h1798.full.pdf
